BCM
ISEE

Bluefin Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bluefin Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-262,300
Closed -$118K – 694
2022
Q3 		$118K Buy
+262,300
New +$3.44M 0.01% 322

Bluefin Capital Management's ISEE Position: Q3 2023 in Review

Bluefin Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 94,904 shares — an estimated $3.73M sold.

Bluefin Capital Management first reported a position in ISEE in Q3 2022 and held it in 2 quarters. The position peaked at $3.73M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Bluefin Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bluefin Capital Management sold 94,904 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.73M.
  • Bluefin Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Bluefin Capital Management's IVERIC bio, Inc. Common Stock position peaked at $3.73M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Bluefin Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.